{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:31:59Z","timestamp":1758990719596},"reference-count":0,"publisher":"SLACK, Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Ophthalmol Strabismus"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:p>&lt;H4&gt;BACKGROUND&lt;\/H4&gt; &lt;p&gt;Recent outbreaks (epidemics) of &lt;I&gt;Streptococcus pneumoniae&lt;\/I&gt; conjunctivitis, involving hundreds of patients, underscore the importance of following recommended guidelines to minimize disease transmission. These include the use of antimicrobial agents capable of minimizing patients\u2019 symptoms and the duration of the infectious period when disease can be transmitted to others.&lt;\/p&gt; &lt;H4&gt;PURPOSE&lt;\/H4&gt; &lt;p&gt;To compare the amount of time required for various antibiotic solutions to kill &lt;I&gt;S. pneumoniae&lt;\/I&gt;, a common cause of bacterial conjunctivitis. &lt;H4&gt;MATERIALS AND METHODS&lt;\/H4&gt; Isolates of &lt;I&gt;S. pneumoniae&lt;\/I&gt; from three patients were exposed to selected ophthalmic antibiotic products: moxifloxacin 0.5%, tobramycin 0.3%, gentamicin 0.3%, and polymyxin B 10,000 IU\u2014trimethoprim 1.0%. The products were diluted 1:100 and 1:1,000 for testing. At 15, 30, 60, 120, and 180 minutes after exposure, aliquots of broth were withdrawn, the cells were separated and cultured, and the viable cell count was determined.&lt;\/p&gt; &lt;H4&gt;RESULTS&lt;\/H4&gt; &lt;p&gt;Moxifloxacin killed actively growing &lt;I&gt;S. pneumoniae&lt;\/I&gt; faster and to a greater extent than did the other three antibiotic products when tested at concentrations corresponding to tear film concentrations 5 to 10 minutes and 30 to 60 minutes after instillation of the products.&lt;\/p&gt; &lt;H4&gt;CONCLUSIONS&lt;\/H4&gt; &lt;p&gt;Moxifloxacin killed &lt;I&gt;S. pneumonia&lt;\/I&gt;e in vitro faster than did the other antibiotics. Consequently, its use should complement other generally accepted measures for minimizing patients\u2019 symptoms and limiting the contagiousness of bacterial conjunctivitis. Also, this is consistent with the recommendations of other investigators to prescribe the most recent generation of fluoroquinolone antibiotics for the specific purpose of limiting the spread of bacterial resistance.&lt;\/p&gt; &lt;p&gt;&lt;CITE&gt;J Pediatr Ophthalmol Strabismus&lt;\/CITE&gt; 2006;43:19-26.&lt;\/p&gt; &lt;H4&gt;AUTHORS&lt;\/H4&gt; &lt;p&gt;Dr. Lichtenstein is from the University of Illinois at Peoria, University of Illinois at Chicago, Chicago, Illinois. Dr. Dorfman is from the Joe DiMaggio Children\u2019s Hospital, Hollywood, Florida. Dr. Kennedy is from North Texas Ophthalmic Plastic Surgery, Fort Worth, Texas. Dr. Stroman is from Alcon Research, Ltd, Fort Worth, Texas.&lt;\/p&gt; &lt;p&gt;Originally submitted September 7, 2005.&lt;\/p&gt; &lt;p&gt;Accepted for publication October 14, 2005.&lt;\/p&gt; &lt;p&gt;Address reprint requests to David Stroman, PhD, Alcon Research, Ltd, 6201 South Freeway, Fort Worth, TX 76134.&lt;\/p&gt; &lt;p&gt;This trial was funded by Alcon Research, Ltd, Fort Worth, Texas. Drs. Lichtenstein and Kennedy have served as consultants to Alcon Research, Ltd. The authors have no relevant financial interest in any drug mentioned in this article.&lt;\/p&gt;<\/jats:p>","DOI":"10.3928\/01913913-20060101-02","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T17:58:50Z","timestamp":1578419930000},"page":"19-26","source":"Crossref","is-referenced-by-count":14,"title":["Controlling Contagious Bacterial Conjunctivitis"],"prefix":"10.3928","volume":"43","member":"2308","container-title":["Journal of Pediatric Ophthalmology &amp; Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/ophthalmology\/journals\/jpos\/2006-1-43-1\/%7B36d0697e-429a-44ae-8a4f-c3c0b3710a1e%7D\/controlling-contagious-bacterial-conjunctivitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T21:58:21Z","timestamp":1683064701000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/01913913-20060101-02"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.3928\/01913913-20060101-02"],"URL":"https:\/\/doi.org\/10.3928\/01913913-20060101-02","relation":{},"ISSN":["0191-3913","1938-2405"],"issn-type":[{"value":"0191-3913","type":"print"},{"value":"1938-2405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}